57130 Federal Register / Vol. 88, No. 161 / Tuesday, August 22, 2023 / Notices 

the Act. The Department of Justice 

published a notice in the Federal 

Register pursuant to section 6(b) of the 

Act on August 1, 2022 (87 FR 47007). 

The last notification was filed with 

the Department on October 26, 2022. A 

notice was published in the Federal 

Register pursuant to section 6(b) of the 

Act on January 24, 2023 (88 FR 4208). 

Suzanne Morris, 

Deputy Director Civil Enforcement 

Operations, Antitrust Division. 

[FR Doc. 2023–18058 Filed 8–21–23; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Antitrust Division 

Notice Pursuant to The National 

Cooperative Research and Production 

Act of 1993—DVD Copy Control 

Association 

Notice is hereby given that, on June 

15, 2023, pursuant to section 6(a) of the 

National Cooperative Research and 

Production Act of 1993, 15 U.S.C. 4301 

et seq. (‘‘the Act’’), the DVD Copy 

Control Association (‘‘DVD CCA’’) has 

filed written notifications 

simultaneously with the Attorney 

General and the Federal Trade 

Commission disclosing changes in its 

membership. The notifications were 

filed for the purpose of extending the 

Act’s provisions limiting the recovery of 

antitrust plaintiffs to actual damages 

under specified circumstances. 

Specifically, Hagiwara (Shanghai) Co., 

Ltd., Shanghai, PEOPLE’S REPUBLIC 

OF CHINA; and Homenema Technology 

Inc., Taipei Hsien, TAIWAN, have 

withdrawn as parties to this venture. 

No other changes have been made in 

either the membership or planned 

activity of the group research project. 

Membership in this group research 

project remains open, and DVD CCA 

intends to file additional written 

notifications disclosing all changes in 

membership. 

On April 11, 2001, DVD CCA filed its 

original notification pursuant to section 

6(a) of the Act. The Department of 

Justice published a notice in the Federal 

Register pursuant to section 6(b) of the 

Act on August 3, 2001 (66 FR 40727). 

The last notification was filed with 

the Department on March 8, 2023. A 

notice was published in the Federal 

Register pursuant to section 6(b) of the 

Act on March 27, 2023 (88 FR 18179). 

Suzanne Morris, 

Deputy Director Civil Enforcement 

Operations, Antitrust Division. 

[FR Doc. 2023–18054 Filed 8–21–23; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Antitrust Division 

Notice Pursuant to the National 

Cooperative Research and Production 

Act of 1993—National Shipbuilding 

Research Program 

Notice is hereby given that, on May 

24, 2023, pursuant to section 6(a) of the 

National Cooperative Research and 

Production Act of 1993, 15 U.S.C. 4301 

et seq. (‘‘the Act’’), National 

Shipbuilding Research Program 

(‘‘NSRP’’) has filed written notifications 

simultaneously with the Attorney 

General and the Federal Trade 

Commission disclosing changes in its 

membership. The notifications were 

filed for the purpose of extending the 

Act’s provisions limiting the recovery of 

antitrust plaintiffs to actual damages 

under specified circumstances. 

Specifically, VT Halter Marine, Inc., 

Pascagoula, MS, has withdrawn as a 

party to this venture. 

No other changes have been made in 

either the membership or planned 

activity of the group research project. 

Membership in this group research 

project remains open, and NSRP intends 

to file additional written notifications 

disclosing all changes in membership. 

On March 13, 1998, NSRP filed its 

original notification pursuant to section 

6(a) of the Act. The Department of 

Justice published a notice in the Federal 

Register pursuant to section 6(b) of the 

Act on January 29, 1999 (64 FR 4708). 

The last notification was filed with 

the Department on October 24, 2022. A 

notice was published in the Federal 

Register pursuant to section 6(b) of the 

Act on November 8, 2022 (87 FR 67492). 

Suzanne Morris, 

Deputy Director Civil Enforcement 

Operations, Antitrust Division. 

[FR Doc. 2023–18062 Filed 8–21–23; 8:45 am] 

BILLING CODE 4410–11–P 

DEPARTMENT OF JUSTICE 

Antitrust Division 

Notice Pursuant to the National 

Cooperative Research and Production 

Act of 1993—Utility Broadband 

Alliance, Inc. 

Notice is hereby given that, on May 

30, 2023, pursuant to section 6(a) of the 

National Cooperative Research and 

Production Act of 1993, 15 U.S.C. 4301 

et seq. (‘‘the Act’’), Utility Broadband 

Alliance, Inc. (‘‘UBBA’’) has filed 

written notifications simultaneously 

with the Attorney General and the 

Federal Trade Commission disclosing 

changes in its membership. The 

notifications were filed for the purpose 

of extending the Act’s provisions 

limiting the recovery of antitrust 

plaintiffs to actual damages under 

specified circumstances. Specifically, 

ATT Business, Dallas, TX; and Aetheros 

Inc., San Francisco, CA, have been 

added as parties to this venture. 

Also, Thales, Bellevue, WA; 

Cambridge Consultants, Boston, MA; 

Tilson, Portland, ME; and CrescoNet, 

San Francisco, CA, have withdrawn as 

parties to this venture. 

No other changes have been made in 

either the membership or planned 

activity of the group research project. 

Membership in this group research 

project remains open, and UBBA 

intends to file additional written 

notifications disclosing all changes in 

membership. 

On May 4, 2021, UBBA filed its 

original notification pursuant to section 

6(a) of the Act. The Department of 

Justice published a notice in the Federal 

Register pursuant to section 6(b) of the 

Act on June 10, 2021 (86 FR 30981). 

The last notification was filed with 

the Department on March 8, 2023. A 

notice was published in the Federal 

Register pursuant to section 6(b) of the 

Act on March 27, 2023 (88 FR 18184). 

Suzanne Morris, 

Deputy Director Civil Enforcement 

Operations, Antitrust Division. 

[FR Doc. 2023–18060 Filed 8–21–23; 8:45 am] 

BILLING CODE 4410–11–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1239] 

Bulk Manufacturer of Controlled 

Substances Application: Pisgah 

Laboratories Inc. 

AGENCY: Drug Enforcement 

Administration, Justice. 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 88, No. 161 / Tuesday, August 22, 2023 / Notices 57131 

ACTION: Notice of application. 

SUMMARY: Pisgah Laboratories Inc. has 

applied to be registered as a bulk 

manufacturer of basic class(es) of 

controlled substance(s). Refer to 

Supplementary Information listed below 

for further drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before October 23, 2023. Such 

persons may also file a written request 

for a hearing on the application on or 

before October 23, 2023. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.33(a), this 

is notice that on July 10, 2023, Pisgah 

Laboratories Inc, 3222 Old 

Hendersonville Highway, Pisgah Forest, 

North Carolina 28768, applied to be 

registered as a bulk manufacturer of the 

following basic class(es) of controlled 

substance(s): 

Controlled substance Drug 

code Schedule 

Ibogaine ........................ 7260 I 

Tapentadol .................... 9780 II 

The company plans to bulk 

manufacture the above-listed controlled 

substances in bulk for internal research 

purposes and distribution to its 

customers. No other activities for these 

drug codes are authorized for this 

registration. 

Claude Redd, 

Acting Deputy Assistant Administrator. 

[FR Doc. 2023–17971 Filed 8–21–23; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1249] 

Bulk Manufacturer of Controlled 

Substances Application: Irvine Labs 

Inc. 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Irvine Labs Inc. has applied to 

be registered as a bulk manufacturer of 

basic class(es) of controlled 

substance(s). Refer to SUPPLEMENTARY

INFORMATION listed below for further 

drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before October 23, 2023. Such 

persons may also file a written request 

for a hearing on the application on or 

before October 23, 2023. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.33(a), this 

is notice that on July 10, 2023, Irvine 

Labs Inc., 7305 Murdy Circle, 

Huntington Beach, California 92647– 

3533, applied to be registered as a bulk 

manufacturer of the following basic 

class(es) of controlled substance(s): 

Controlled substance Drug 

code Schedule 

Diethyltryptamine .................... 7434 I 

Dimethyltryptamine ................. 7435 I 

Lysergic acid diethylamide ..... 7315 I 

Mescaline ................................ 7381 I 

Peyote ..................................... 7415 I 

Psilocybin ................................ 7437 I 

Psilocyn ................................... 7438 I 

The company plans to bulk 

manufacture the above listed controlled 

substances for research and 

development purposes internally and 

for distribution to its research 

customers. No other activities for these 

drug codes are authorized for this 

registration. 

Claude Redd, 

Acting Deputy Assistant Administrator. 

[FR Doc. 2023–17984 Filed 8–21–23; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1247] 

Bulk Manufacturer of Controlled 

Substances Application: Cambrex 

Charles City 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Cambrex Charles City has 

applied to be registered as a bulk 

manufacturer of basic class(es) of 

controlled substance(s). Refer to 

SUPPLEMENTARY INFORMATION listed 

below for further drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before October 23, 2023. Such 

persons may also file a written request 

for a hearing on the application on or 

before October 23, 2023. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.33(a), this 

is notice that on July 3, 2023, Cambrex 

Charles City, 1205 11th Street, Charles 

City, Iowa 50616–3466, applied to be 

registered as a bulk manufacturer of the 

following basic class(es) of controlled 

substance(s): 


lotter on DSK11XQN23PROD with NOTICES1